This study confirms that the regulatory effect of VRAC on the NLRP3 inflammasome may facilitate the establishment of a novel research field for understanding the pathogenesis of Alzheimer's disease, atherosclerosis, and other NLRP3-associated diseases. The gene discussed is NLRP3; the disease is early-onset autosomal dominant Alzheimer disease.